Rivastigmine

BNF:
4.11
Status:
Green - after consultant/specialist initiation
Decision Date:
None
 

Comments

GREEN: 2nd line (for dementia) after consultant/specialist initiation and stabilisation for 3 months. (Decision date - March 2017)

See management of dementia in primary care.

GREEN after consultant/specialist initiation: treatment options for Parkinson’s Dementia for psychosis, aggression, and agitation/anxiety as per NICE NG71 recommendations. (See Managing Behavioural Problems in Patients with Dementia guideline) (Decision date - April 2023)

  • Starting dose for PDDC - 1.5mg BD (oral capsules)
  • Maintenance dose range - 3mg - 6mg BD (oral capsules)
  • Maximum dose - 6mg BD (oral capsules)
  • Rivastigmine patches may be an option if oral capsules are poorly tolerated or if carers have problems administering them

 

(Alzest patches are the preferred cost effective choice)

search again